- Consist of
- Summary
Langerhan cell Histiocytosis | Erdheim Chester disease (house) | Rosai-Dorfman disease | Juvenile xanthogranuloma | Histiocytic sarcoma | |
Aetiology | Abnormal immune response | Nil | Nil | Nil | Radiation |
Localization | • Craniofacial and skull base • Hypothalamic pituitary region • Meninges • Choroid plexus • Basal ganglia • Dentate nucleus | • Brain (preferentially the cerebellum and brain stem), • Spinal cord | • Dural>Parenchymal • Cerebral convexity, • Cranial base, • Cavernous sinuses • Neck | • Brain (53%), • Intradural extramedullary spine (13%) • Nerve roots (15%) | • Brain parenchyma • Meninges • Cavernous sinus |
5 yr survival | 88% | Nil | Nil | Nil | Nil |
Genetic profile | BRAF V600E MAP2K1 | BRAF V600E mutations 50% NRAS 17% PIK3CA 12% | Nil | Nil | Lack IGH or T cell receptor gene clonality |
Macroscopic | Yellow/white Dural base Parenchymal infiltrates | Infiltrative parenchymal lesions (44%), dural thickening / a meningioma-like mass (37%) A combination {19%) | Firm Lobulated Yellow-greyish white dural mass | Fragmented soft yellow to tan-pink | Destructive Soft Fleshy white Yellow necrotic foci |
Clinical features | • Neurogenic diabetes insipidus • Psychomotor deterioration and ataxia • Obstruction hydrocephalus | • Cerebellar signs (41%) • Pyramidal syndromes (45%) • Diabetes insipidus (47%) | • H/a • N/V • Dizzy • Hypopit and DI | • Seizure • DI • Visual disturbances | • Variable • Progressive |
Average Age | 2yrs | 53 yrs | 21 yrs | 2 yrs | 52 yrs |
Infiltrate composition Special cell/s(x) | • Langerhans cells, • Macrophages, • Lymphocytes, • Plasma cells, • Variable eosinophils Touton giant cell | Lipid-laden histiocytes with small nuclei Touton-type giant cells, scant lymphocytes, rare eosinophils, and variable fibrosis or gliosis. | • Large pale histiocytes, • (n) lymphocytes • (n) plasma cells, • Variable fibrosis. • Emperipolesis | • Composed of rounded to spindled, variably vacuolated histiocytes, • Scattered Touton and foreign body-type giant cells, • Lymphocytes, • Eosinophils | Highly cellular, mitotically active histiocytes with abundant eosinophilic cytoplasm |
Imaging | Lack of T1 hyper intensity in post pit but there is enhancement of infundibulum | Resemble meningioma Delayed gadolinium enhancement | Resemble meningioma | Nil | Nil |
Prognosis | Good for Unifocal disease | Good esp having BRAF V600E | Nil | Nil | Nil |
Immunophenotype + | CD1a Langerin CD207 S100 | CD68 | • CD11c • CD68 • L1 antigen (clone MAC387) • S100 protein | • CD11c • CD68 • Factor XII | • Histiocytic markers (e.g. CD68, CD163, lysozyme, CD11c, and CD14) |